Vaccine Development Against Middle East Respiratory Syndrome.
Identifieur interne : 000E52 ( PubMed/Checkpoint ); précédent : 000E51; suivant : 000E53Vaccine Development Against Middle East Respiratory Syndrome.
Auteurs : Hai Yen Lee [Malaisie] ; Mun Peak Nyon [Malaisie] ; Ulrich Strych [États-Unis]Source :
- Current tropical medicine reports [ 2196-3045 ] ; 2016.
Abstract
Various types of vaccines are under pre-clinical and clinical development to address the recent appearance of Middle East respiratory syndrome or MERS, an emerging infectious disease that has already caused over 600 deaths and remains a threat to world health. The causative agent for this respiratory disease is a member of the betacoronavirus genus, phylogenetically closely related to the SARS coronavirus that caused an international health emergency in 2002. With lessons learned from the outbreak of severe acute respiratory syndrome, and with undeniable technological advances, vaccine development against MERS was initially fast-paced and has produced several DNA and protein vaccine candidates with promising results during early pre-clinical testing. At least one vaccine candidate has even entered first-in-humans clinical trials now. With the number of MERS cases declining though and other infectious diseases attracting increased attention, the question remains, whether, similar to the situation after the SARS pandemic, vaccine development is halted or remains the priority it rightfully should.
DOI: 10.1007/s40475-016-0084-0
PubMed: 32226714
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32226714Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccine Development Against Middle East Respiratory Syndrome.</title><author><name sortKey="Lee, Hai Yen" sort="Lee, Hai Yen" uniqKey="Lee H" first="Hai Yen" last="Lee">Hai Yen Lee</name><affiliation wicri:level="1"><nlm:affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur</wicri:regionArea><wicri:noRegion>Kuala Lumpur</wicri:noRegion></affiliation></author><author><name sortKey="Nyon, Mun Peak" sort="Nyon, Mun Peak" uniqKey="Nyon M" first="Mun Peak" last="Nyon">Mun Peak Nyon</name><affiliation wicri:level="1"><nlm:affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur</wicri:regionArea><wicri:noRegion>Kuala Lumpur</wicri:noRegion></affiliation></author><author><name sortKey="Strych, Ulrich" sort="Strych, Ulrich" uniqKey="Strych U" first="Ulrich" last="Strych">Ulrich Strych</name><affiliation wicri:level="2"><nlm:affiliation>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, TX USA.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:32226714</idno><idno type="pmid">32226714</idno><idno type="doi">10.1007/s40475-016-0084-0</idno><idno type="wicri:Area/PubMed/Corpus">001316</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001316</idno><idno type="wicri:Area/PubMed/Curation">001316</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001316</idno><idno type="wicri:Area/PubMed/Checkpoint">000E52</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E52</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccine Development Against Middle East Respiratory Syndrome.</title><author><name sortKey="Lee, Hai Yen" sort="Lee, Hai Yen" uniqKey="Lee H" first="Hai Yen" last="Lee">Hai Yen Lee</name><affiliation wicri:level="1"><nlm:affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur</wicri:regionArea><wicri:noRegion>Kuala Lumpur</wicri:noRegion></affiliation></author><author><name sortKey="Nyon, Mun Peak" sort="Nyon, Mun Peak" uniqKey="Nyon M" first="Mun Peak" last="Nyon">Mun Peak Nyon</name><affiliation wicri:level="1"><nlm:affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</nlm:affiliation><country xml:lang="fr">Malaisie</country><wicri:regionArea>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur</wicri:regionArea><wicri:noRegion>Kuala Lumpur</wicri:noRegion></affiliation></author><author><name sortKey="Strych, Ulrich" sort="Strych, Ulrich" uniqKey="Strych U" first="Ulrich" last="Strych">Ulrich Strych</name><affiliation wicri:level="2"><nlm:affiliation>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, TX USA.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston</wicri:cityArea></affiliation></author></analytic><series><title level="j">Current tropical medicine reports</title><idno type="ISSN">2196-3045</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Various types of vaccines are under pre-clinical and clinical development to address the recent appearance of Middle East respiratory syndrome or MERS, an emerging infectious disease that has already caused over 600 deaths and remains a threat to world health. The causative agent for this respiratory disease is a member of the betacoronavirus genus, phylogenetically closely related to the SARS coronavirus that caused an international health emergency in 2002. With lessons learned from the outbreak of severe acute respiratory syndrome, and with undeniable technological advances, vaccine development against MERS was initially fast-paced and has produced several DNA and protein vaccine candidates with promising results during early pre-clinical testing. At least one vaccine candidate has even entered <i>first-in-humans</i> clinical trials now. With the number of MERS cases declining though and other infectious diseases attracting increased attention, the question remains, whether, similar to the situation after the SARS pandemic, vaccine development is halted or remains the priority it rightfully should.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32226714</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2196-3045</ISSN><JournalIssue CitedMedium="Print"><Volume>3</Volume><Issue>3</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Current tropical medicine reports</Title><ISOAbbreviation>Curr Trop Med Rep</ISOAbbreviation></Journal><ArticleTitle>Vaccine Development Against Middle East Respiratory Syndrome.</ArticleTitle><Pagination><MedlinePgn>80-86</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40475-016-0084-0</ELocationID><Abstract><AbstractText>Various types of vaccines are under pre-clinical and clinical development to address the recent appearance of Middle East respiratory syndrome or MERS, an emerging infectious disease that has already caused over 600 deaths and remains a threat to world health. The causative agent for this respiratory disease is a member of the betacoronavirus genus, phylogenetically closely related to the SARS coronavirus that caused an international health emergency in 2002. With lessons learned from the outbreak of severe acute respiratory syndrome, and with undeniable technological advances, vaccine development against MERS was initially fast-paced and has produced several DNA and protein vaccine candidates with promising results during early pre-clinical testing. At least one vaccine candidate has even entered <i>first-in-humans</i> clinical trials now. With the number of MERS cases declining though and other infectious diseases attracting increased attention, the question remains, whether, similar to the situation after the SARS pandemic, vaccine development is halted or remains the priority it rightfully should.</AbstractText><CopyrightInformation>© Springer International Publishing AG 2016.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hai Yen</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</Affiliation><Identifier Source="GRID">grid.10347.31</Identifier><Identifier Source="ISNI">0000000123085949</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, TX USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX USA.</Affiliation><Identifier Source="GRID">grid.39382.33</Identifier><Identifier Source="ISNI">000000012160926X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyon</LastName><ForeName>Mun Peak</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>1Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur, Malaysia.</Affiliation><Identifier Source="GRID">grid.10347.31</Identifier><Identifier Source="ISNI">0000000123085949</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, TX USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX USA.</Affiliation><Identifier Source="GRID">grid.39382.33</Identifier><Identifier Source="ISNI">000000012160926X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strych</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Houston, TX USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX USA.</Affiliation><Identifier Source="GRID">grid.39382.33</Identifier><Identifier Source="ISNI">000000012160926X</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Curr Trop Med Rep</MedlineTA><NlmUniqueID>101625249</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">MERS</Keyword><Keyword MajorTopicYN="N">RBD</Keyword><Keyword MajorTopicYN="N">SARS</Keyword><Keyword MajorTopicYN="N">Vaccines</Keyword></KeywordList><CoiStatement>Conflict of InterestThe authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32226714</ArticleId><ArticleId IdType="doi">10.1007/s40475-016-0084-0</ArticleId><ArticleId IdType="pii">84</ArticleId><ArticleId IdType="pmc">PMC7099997</ArticleId></ArticleIdList><pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2005 Jul;11(7):1016-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16022774</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Vaccin Immunother. 2013 Sep;9(9):1877-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23877094</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Sci (Lond). 2000 Aug;99(2):93-104</Citation><ArticleIdList><ArticleId IdType="pubmed">10918042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2014 Oct 21;32(46):6170-6176</Citation><ArticleIdList><ArticleId IdType="pubmed">25240756</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2016 Jan 1;351(6268):77-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26678878</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2008 Nov 25;26(50):6338-43</Citation><ArticleIdList><ArticleId IdType="pubmed">18824060</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2014 Oct 14;32(45):5975-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25192975</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603</Citation><ArticleIdList><ArticleId IdType="pubmed">24062443</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>mBio. 2016 Mar 01;7(2):e00019</Citation><ArticleIdList><ArticleId IdType="pubmed">26933050</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2015 Dec 07;10(12):e0144475</Citation><ArticleIdList><ArticleId IdType="pubmed">26641892</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2014 Aug;88(16):9220-32</Citation><ArticleIdList><ArticleId IdType="pubmed">24899185</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Pathog. 2015 Oct 29;11(10):e1005215</Citation><ArticleIdList><ArticleId IdType="pubmed">26513244</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>mBio. 2013 Sep 10;4(5):e00650-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24023385</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Protein Cell. 2013 Dec;4(12):951-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24318862</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2013 Nov;87(21):11950-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23986586</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2015 Apr;89(7):3659-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25589660</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Microbiol Spectr. 2014 Dec;2(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">26104452</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Sci Rep. 2016 Jan 06;6:18825</Citation><ArticleIdList><ArticleId IdType="pubmed">26732651</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antivir Ther. 2007;12(7):1107-13</Citation><ArticleIdList><ArticleId IdType="pubmed">18018769</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2015 Oct 07;90(1):57-67</Citation><ArticleIdList><ArticleId IdType="pubmed">26446606</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Expert Rev Vaccines. 2003 Aug;2(4):465-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14711331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2013 Sep;87(17):9939-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23824801</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2013 Aug 24;382(9893):694-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23831141</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Commun. 2015 Jul 28;6:7712</Citation><ArticleIdList><ArticleId IdType="pubmed">26218507</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2011 Dec;85(23):12201-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21937658</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Immunology. 2015 Aug;145(4):476-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25762305</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Bull World Health Organ. 2004 Feb;82(2):152-3</Citation><ArticleIdList><ArticleId IdType="pubmed">15042239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 2014 Feb;95(Pt 2):408-412</Citation><ArticleIdList><ArticleId IdType="pubmed">24197535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2016 Mar 1;213(5):712-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26486634</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2015 Aug;89(16):8651-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26018172</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Vaccin Immunother. 2014;10(3):648-58</Citation><ArticleIdList><ArticleId IdType="pubmed">24355931</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Expert Rev Vaccines. 2012 Dec;11(12):1405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">23252385</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2004 Feb 13;303(5660):944-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14963300</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2014 May 30;32(26):3169-3174</Citation><ArticleIdList><ArticleId IdType="pubmed">24736006</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS Pathog. 2014 Aug 21;10(8):e1004250</Citation><ArticleIdList><ArticleId IdType="pubmed">25144235</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2007 Apr 12;25(15):2832-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17092615</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2014 Feb;88(3):1834-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24257613</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2013 Mar 9;381(9869):779-81</Citation><ArticleIdList><ArticleId IdType="pubmed">23668493</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2015 Dec 18;350(6267):1453</Citation><ArticleIdList><ArticleId IdType="pubmed">26680169</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>mBio. 2012 Nov 20;3(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2014 May;88(9):4953-61</Citation><ArticleIdList><ArticleId IdType="pubmed">24554656</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2005 May;79(9):5833-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15827197</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>EBioMedicine. 2015 Aug 18;2(10):1438-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26629538</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2015 Jun;15(6):629</Citation><ArticleIdList><ArticleId IdType="pubmed">26008827</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra132</Citation><ArticleIdList><ArticleId IdType="pubmed">26290414</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>PLoS One. 2013 Jul 02;8(7):e69127</Citation><ArticleIdList><ArticleId IdType="pubmed">23844250</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2015 Dec 10;33(50):7135-40</Citation><ArticleIdList><ArticleId IdType="pubmed">26458805</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15024391</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2013 Mar 14;495(7440):176-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23486053</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 2011 Jan 29;29(5):960-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21111785</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Malaisie</li><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="Malaisie"><noRegion><name sortKey="Lee, Hai Yen" sort="Lee, Hai Yen" uniqKey="Lee H" first="Hai Yen" last="Lee">Hai Yen Lee</name></noRegion><name sortKey="Nyon, Mun Peak" sort="Nyon, Mun Peak" uniqKey="Nyon M" first="Mun Peak" last="Nyon">Mun Peak Nyon</name></country><country name="États-Unis"><region name="Texas"><name sortKey="Strych, Ulrich" sort="Strych, Ulrich" uniqKey="Strych U" first="Ulrich" last="Strych">Ulrich Strych</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E52 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000E52 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32226714
|texte= Vaccine Development Against Middle East Respiratory Syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32226714" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |